Sulazepam
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H13ClN2S |
| Molar mass | 300.81 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Sulazepam[1] is a drug which is a benzodiazepine derivative. It is the thioamide derivative of diazepam. It is metabolised into diazepam, desmethyldiazepam and oxydiazepam. It has sedative, muscle relaxant, hypnotic, anticonvulsant and anxiolytic properties like those of other benzodiazepines.[2][3]
See also
References
- ^ US Patent 3141890
- ^ "sulazepam". psychotropics.dk. 2003. Retrieved 29 December 2008.
- ^ Golovenko NIa, Zin'kovskii VG (1976). "(title in Russian)". Biull Eksp Biol Med (in Russian). 82 (9): 1078–1081. PMID 11012.
{{cite journal}}: Unknown parameter|month=ignored (help); Unknown parameter|trans_title=ignored (|trans-title=suggested) (help)
 | This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |